Chip-based Oligonucleotide Synthesis Market Size is USD 62.81 Million in 2026

The global chip-based oligonucleotide synthesis market, valued at USD 50.78 million in 2025, is projected to reach USD 401.91 million by 2035, growing at a CAGR of 22.98% driven by advancements in genomics, biotechnology, and personalized medicine.

Chip-based Oligonucleotide Synthesis Market Statical Scope

The chip-based oligonucleotide synthesis market growth is driven by diagnostics and personalized medicines, next-generation sequencing and gene editing, automation & artificial intelligence AI, and RNA-based therapeutics. However, the restraining factors of the market include use of hazardous reagents, waste generation, market uncertainties, market penetration, cost constraints, quality and consistency, synthesis complexity & errors, and maintaining speed & accuracy is difficult. Regional expansion, contract services, growing demand for modified oligonucleotides, high-throughput synthesis, and advances in gene editing technologies will help the growth of the market in the future.

The chip-based oligonucleotide synthesis market is expected to grow rapidly due to the integration of artificial intelligence (AI). AI applications in chemical reactions include condition recommendations, retrosynthetic planning, and forward reaction prediction. Additionally, AI allows the automation of compound synthesis and reduces the repetitive work of laboratory staff. AI models exhibit impressive accuracy when predicting molecular properties, including toxicity, stability, and solubility.

Chip-based Oligonucleotide Synthesis Market Share, By Region, 2025 (%)

• North America (40%) — The leading region for the chip-based oligonucleotide synthesis market due to advanced research and development infrastructure.
• Europe (25%) — A mature market with significant contributions from pharmaceutical and biotech companies engaged in oligonucleotide-based research.
• Asia Pacific (20%) — Growing market driven by expanding biotechnology sectors, especially in countries like China and India.
• LAMEA (15%) — Emerging market with slower growth due to limited access to advanced biotechnology infrastructure.

Chip-based Oligonucleotide Synthesis Market Share, By Type, 2025 (%)

• Photochemical Method (35%) — A technique where light initiates the chemical reactions necessary for oligonucleotide synthesis on a chip.
• Electrochemical Method (30%) — Uses electrical signals to drive the chemical reactions that synthesize oligonucleotides on a chip.
• Inkjet Printing Method (35%) — A printing-based technology that applies reagents in small droplets to synthesize oligonucleotides directly onto a chip.

Chip-based Oligonucleotide Synthesis Market Share, By Application, 2025 (%)

• Scientific Research (60%) — The dominant application of oligonucleotide synthesis, used for gene sequencing, diagnostics, and other molecular biology research.
• Others (40%) — Includes applications in diagnostics, therapeutics, and other fields outside of scientific research.

Chip-based Oligonucleotide Synthesis Market Companies

• Thermo Fisher
• GenScript
• LC Sciences
• Twist Bioscience
• Agilent Technologies
• Evonetix
• Dynegene Technologies
• LC-Bio Technologies
• Atantares
• BGI Genomics

Chip-based Oligonucleotide Synthesis Market Segmentation

By Type

• Photochemical Method
• Electrochemical Method
• Inkjet Printing Method

By Application

• Scientific Research
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa